SEC Form 4 · accession 0001209191-19-001165
Translate Bio, Inc. · TBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Meyer
Director
Period of report
Jan 2, 2019
Accepted (ET)
Jan 3, 2019 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001693415
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.49 | Jan 2, 2019 | A | 37,800 | A | — | Jan 1, 2029 | Common Stock | 37,800 | 37,800 | D |
Explanation of responses
- F1The shares underlying this option are scheduled to vest and become exercisable in equal monthly installments, beginning on February 2, 2019 and ending on the three year anniversary of January 2, 2019.